Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Archives of internal medicine - 11 Nov 2002

Eichinger Sabine, Weltermann Ansgar, Mannhalter Christine, Minar Erich, Bialonczyk Christine, Hirschl Mirko, Schönauer Verena, Lechner Klaus, Kyrle Paul A

Abstract excerpt

BACKGROUND: Factor V (FV) Leiden is a risk factor for venous thrombosis (VT). Data on its influence on the risk of recurrent venous thromboembolism (VTE) are controversial owing to different study designs and patient cohorts. METHODS: We reevaluated the risk of recurrence among heterozygous carri...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cohort Studies
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heterozygote

Share to Recurrence

Share to Risk Assessment

Share to Thromboembolism

Share to Venous Thrombosis

Source

Identifiers

PMID: 12418950
DOI: 10.1001/archinte.162.20.2357

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12418950-2026-09-02.1. Manifest publication-graph-cohort-2026-09-02.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.PMID 12418950Read ↗

The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationSemantic proximity Read ↗

The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.Semantic proximity Read ↗

Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.Semantic proximity Read ↗

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.Semantic proximity Read ↗

Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.Semantic proximity Read ↗

The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation.Semantic proximity Read ↗

Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.Semantic proximity Read ↗

Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis.Semantic proximity Read ↗

Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis.Semantic proximity Read ↗

G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.Semantic proximity Read ↗

Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.Semantic proximity Read ↗

Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.